Search
Descriptor English: Dual Anti-Platelet Therapy
Descriptor Spanish: Terapia Antiplaquetaria Doble
Descriptor tratamiento antiagregante plaquetario doble
Scope note: Tratamiento con una combinación de dos tipos de antiagregantes plaquetarios para prevenir la coagulación de la sangre, generalmente ÁCIDO ACETILSALICÍLICO y otro de los INHIBIDORES DE LA AGREGACIÓN PLAQUETARIA.
Descriptor Portuguese: Terapia Antiplaquetária Dupla
Descriptor French: Bithérapie antiplaquettaire
Entry term(s): Anti-Platelet Therapies, Dual
Anti-Platelet Therapy, Dual
Dual Anti Platelet Therapy
Dual Anti-Platelet Therapies
Tree number(s): E02.319.310.537
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000080903
Scope note: Treatment with a combination of two types of antiplatelet agents to prevent blood clotting - usually ASPIRIN and another of the PLATELET AGGREGATION INHIBITORS.
Allowable Qualifiers: AE adverse effects
CL classification
EC economics
ES ethics
HI history
IS instrumentation
MO mortality
MT methods
NU nursing
PX psychology
SN statistics & numerical data
ST standards
TD trends
VE veterinary
Previous Indexing: Platelet Aggregation Inhibitors (2001-2019)
Public MeSH Note: 2020
History Note: 2020
Related: Platelet Aggregation Inhibitors MeSH
DeCS ID: 59085
Unique ID: D000080903
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2020/01/01
Date of Entry: 2019/07/08
Revision Date: 2019/05/30
Dual Anti-Platelet Therapy - Preferred
Concept UI M000648697
Scope note Treatment with a combination of two types of antiplatelet agents to prevent blood clotting - usually ASPIRIN and another of the PLATELET AGGREGATION INHIBITORS.
Preferred term Dual Anti-Platelet Therapy
Entry term(s) Anti-Platelet Therapies, Dual
Anti-Platelet Therapy, Dual
Dual Anti Platelet Therapy
Dual Anti-Platelet Therapies



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey